1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
(
- Contribution to journal › Article
- 2022
-
Mark
Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization
2022) In Proceedings of the National Academy of Sciences of the United States of America 119(9). p.1-11(
- Contribution to journal › Article
- 2014
-
Mark
Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas.
(
- Contribution to journal › Article
- 2010
-
Mark
Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.
(
- Contribution to journal › Article
- 2009
-
Mark
CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
(
- Contribution to journal › Article
-
Mark
Immunizations With IFN gamma Secreting Tumor Cells can Eliminate Fully Established and Invasive Rat Gliomas
(
- Contribution to journal › Article
-
Mark
Bone Marrow Multipotent Mesenchymal Stroma Cells Act as Pericyte-like Migratory Vehicles in Experimental Gliomas.
(
- Contribution to journal › Article
-
Mark
Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
(
- Contribution to journal › Article